Table of Contents

About the Platform

We offer a targeted lipidomics method as our preferred tool for investigating lipids in disease-associated systems. This broad targeted approach leverages a conserved chemical logic of glycerolipids, sphingolipids, and sterols to measure relative levels of specific lipid molecules. We work with investigators to reach a clear, directed interpretation of the data. While relative quantitation often provides adequate information to resolve most lipid hypotheses, there is the possibility for pseudo-absolute quantification (quantification based on similarity to internal standards) as well as customization of the panel. Please indicate in the project request form the level of quantification (e.g., relative vs. pseudo-absolute) required and details can be discussed during consultation.

  • Measurement of 1750 individual lipids.
  • Acyl-chain resolution (i.e., length, number of double bonds) of phosphatidylethanolamine, phosphatidylcholine, sphingomyelin, ceramide, hexosylceramide, lactosylceramide, dihydroceramide, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, Ether-PE, triacylglycerol, diacylglycerol, monoacylglycerol, cholesterol esters, free fatty acids, and lysophospholipids.
  • Compatibility with a wide range of biological matrices.


Please consult with the NIAID Core Director for cost information.



  • Project requests should be directed to the Trans-NIH Metabolomics Core.
  • Questions about this offering should be directed to Benjamin (Benji) Schwarz, Ph.D.
Benji Schwarz, Ph.D.
Benji Schwarz, Ph.D.
Staff Scientist
Tel 406-363-9285
[email protected]